This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Verisk Health’s HEDIS Solution Fully Certified And Ready For The 2012 Season

Stocks in this article: VRSK

Verisk Health announced that its HEDIS® Performance Measurement solution has been certified by the National Committee for Quality Assurance (NCQA) and is ready for 2012 Healthcare Effectiveness Data and Information Set (HEDIS) reporting. This year marks the 11 th straight season that the company has achieved full certification. Verisk Health is a global leader in risk management solutions and a long-standing NCQA® HEDIS Software Certification beta-testing partner.

“We’re pleased to once again deliver a fully-certified HEDIS solution so early in the 2012 reporting season,” said Nathan Gunn, MD, president of the Enterprise Analytics Division of Verisk Health. “And, we are excited to offer a solution optimized to further reduce run time, thereby providing the timely, monthly reporting that is critical to strategic initiatives such as Five Star quality improvement programs.”

To make sure that HEDIS stays current, the NCQA has established a process to update the measurements annually. The NCQA HEDIS Software Certification process requires solution providers to re-certify each year to ensure compliance with the latest quality measures. Verisk Health has a long-standing partnership with NCQA, achieving certification each year since 2001 and acting as a certification beta-testing vendor for the organization since 2003.

The Verisk Health HEDIS Performance Measurement solution is used by payers and providers to track, measure, and benchmark adherence to clinical standards. It enables managed care organizations to view results quickly and easily for each HEDIS measure, sample, and chase calculation performed. Key uses of the product include:

  • calculating HEDIS measures from source healthcare data
  • analyzing HEDIS data using robust filters, drills, and reports
  • collecting hybrid medical record data
  • developing custom measures for clinical reporting initiatives
  • access to secure, web-enabled software that facilitates the communication, planning, and managing of projects and checkpoints related to HEDIS measure production
  • access to chart review tools and services

Please join us February 22 from 1-2 p.m. Eastern time for a complimentary webinar entitled Improving Quality Outcomes Through Effective HEDIS Reporting. Click here to register

About Verisk Health

Verisk Health, a subsidiary of Verisk Analytics (Nasdaq:VRSK), helps organizations identify, manage, and mitigate healthcare risk to improve quality, reduce costs, and maximize profitability. Our data-driven risk assessment technologies and business decision analytics enable clients to proactively seize opportunities for improving clinical, financial, and performance results. Our solutions optimize the efficiency of key business objectives, including care management; risk identification and stratification; HEDIS compliance; benefit program measurement; fraud, waste, and abuse prevention; payment accuracy; and revenue cycle management. For more information, please visit www.veriskhealth.com.

HEDIS® is a registered trademark of the NCQACertified HEDIS® Software is a service mark of the NCQAHEDIS® Software Certification is a service mark of the NCQA

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,461.32 -153.49 -0.92%
S&P 500 1,927.11 -14.17 -0.73%
NASDAQ 4,382.8470 -36.6310 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs